New Technology for Managing Non-Dysplastic Barrett's Esophagus (DDW 2023)

Castle Biosciences hosted a case-based panel discussion highlighting how new precision medicine testing can aid in the management of non-dysplastic Barrett’s esophagus patients.

Moderated by Castle Biosciences' Medical Director Matthew Goldberg, MD, the panel included:

-- John Lipham, MD, Professor of Surgery, Keck of Medicine of USC;
-- Harshit Khara, MD, FACG, FASGE, Director of Endoscopy, Geisinger Medical Center;
-- Raman Muthusamy, MD, MAS, Medical Director of Endoscopy, UCLA

0:00 Introductions
1:28 What are the main challenges in managing patients with Barrett's esophagus?
3:33 Overview of TissueCypher
7:12 Case Study No. 1
12:56 Overview of 2022 AGA Clinical Practice Update
18:16 Case Study No. 2
25:22 Case Study No. 3
30:52 Discussion on Clinical Utility

Want to talk to us about TissueCypher? Contact us here: https://castlebiosciences.com/company...